| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.033 | 0.8 |